There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open5,826
High5,897
Low5,665
Prev. Close5,831
Avg. Traded Price5,839.87
Volume9,403
MARKET DEPTH
Total bid2.00
Total ask0.00
Orders
Qty
Bid
2
2
5831
0
0
0
0
0
0
0
0
0
0
0
0
Ask
Qty
Orders
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
HIGH/LOW
1d
1w
1m
3m
52w
LOW/HIGH
₹5,665.0016 hours ago
₹5,897.0015 hours ago
LOWER/UPPER CIRCUITS
₹4,672.00
₹7,007.00
Procter And Gamble Health Ltd Stock performance
KEY OBSERVATIONS
positive
negative
neutral
Annual Net Profit,rose 2.15% in the last year to ₹234.41 Cr. Its sector's average net profit growth for the last fiscal year was 38.6%.
Price to Earning Ratio,is 38.59, lower than its sector PE ratio of 41.83.
Return on Equity(ROE),for the last financial year was 43.65%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more
LONG-TERM PRICE ANALYSIS
Stock return5Y CAGR : 4.98%
Net profit growth 5Y CAGR : 19.56%
Procter And Gamble Health Ltd Top mutual funds holding
Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018 the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. On December 1st 2018 it successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions.
Grow your wealth with more research recommendations